A Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-386 in Healthy Male Volunteers

NCT03920579 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension
Dyslipidemias

Interventions

DRUG: CKD-386 formulation 1
DRUG: CKD-386 formulation 2
DRUG: D326, D337 and D013

Sponsor

Chong Kun Dang Pharmaceutical